Schroder Investment Management Group Grows Stake in Henry Schein, Inc. (HSIC)
Schroder Investment Management Group raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 313,588 shares of the company’s stock after buying an additional 8,492 shares during the quarter. Schroder Investment Management Group owned about 0.40% of Henry Schein worth $57,192,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in HSIC. BlackRock Inc. grew its holdings in shares of Henry Schein by 2,999.6% during the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock worth $951,028,000 after buying an additional 5,414,761 shares in the last quarter. MARSHALL WACE ASIA Ltd purchased a new stake in shares of Henry Schein during the first quarter worth $50,281,000. Marshall Wace North America L.P. purchased a new stake in shares of Henry Schein during the first quarter worth $50,281,000. PGGM Investments purchased a new stake in shares of Henry Schein during the second quarter worth $32,623,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Henry Schein by 12.4% during the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock worth $257,650,000 after buying an additional 167,213 shares in the last quarter. 89.11% of the stock is owned by institutional investors and hedge funds.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) opened at 175.34 on Friday. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The stock’s 50 day moving average is $174.96 and its 200 day moving average is $176.25. The firm has a market cap of $13.86 billion, a PE ratio of 25.62 and a beta of 1.10. Henry Schein shares are set to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly issued shares will be payable to shareholders after the closing bell on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.73 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. Henry Schein’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.64 EPS. On average, analysts anticipate that Henry Schein, Inc. will post $7.27 earnings per share for the current fiscal year.
A number of equities research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, May 24th. Piper Jaffray Companies assumed coverage on shares of Henry Schein in a report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price objective for the company. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. Credit Suisse Group reissued a “hold” rating and issued a $160.00 price objective on shares of Henry Schein in a report on Thursday, July 13th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $177.00 price objective on shares of Henry Schein in a report on Friday, July 21st. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have issued a buy rating to the company’s stock. Henry Schein currently has a consensus rating of “Hold” and a consensus price target of $186.50.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.